Dean J. Mitchell

Companies

• Praxis Precision Medicines, Inc.Board member Oct 15, 2020 to now¹
• Theravance Biopharma, Inc.Board member Jun 5, 2014 to now²
• Kinnate Biopharma Inc.Board member Dec 2, 2020 to Apr 5, 2024³
• Precigen, IncBoard member Aug 7, 2013 to Mar 18, 2024⁴
• ImmunoGen Inc.Board member Feb 1, 2012 to Feb 12, 2024⁵
• Bristol-Myers SquibbPresident Sep 12, 2003 to Sep 12, 2003⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPPraxis Precision Medicines, Inc. PRAX18,622 shares⁷$4.8M at $259.50Jun 10, 2026
• Bristol-Myers Squibb BMY60,568 shares⁸$3.7M at $60.95Sep 12, 2003
• Precigen, Inc PGEN503,183 shares⁹$3.3M at $6.58Mar 14, 2024
• IImmunoGen Inc. IMGN0 shares¹⁰Feb 12, 2024
• TBTheravance Biopharma, Inc. TBPH0 shares¹¹Sep 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 23, 2026Returned to company 6,009 shares of Theravance Biopharma, Inc.¹¹
• Sep 23, 2026Returned to company 91,204 shares of Theravance Biopharma, Inc.¹¹
• Jun 12, 2026Granted 6,009 shares of Theravance Biopharma, Inc.¹²
• Jun 10, 2026Granted 1,371 shares of Praxis Precision Medicines, Inc.⁷
• Sep 24, 2025Exercised options 1,753 shares at $44.04 of Praxis Precision Medicines, Inc.¹³
• Sep 24, 2025Exercised options 8,566 shares at $44.25 of Praxis Precision Medicines, Inc.¹³
• Sep 24, 2025Exercised options 1,932 shares at $14.36 of Praxis Precision Medicines, Inc.¹³
• May 19, 2025Granted 10,649 shares of Theravance Biopharma, Inc.¹⁴
• May 8, 2024Granted 10,537 shares of Theravance Biopharma, Inc.¹⁵
• Mar 14, 2024Granted 39,510 shares at $1.43 of Precigen, Inc⁹
• Mar 9, 2024Exercised options 106,837 shares of Precigen, Inc¹⁶
• Feb 12, 2024Returned to company 103,000 shares of ImmunoGen Inc.¹⁰
• Sep 22, 2023Exercised options 10,000 shares at $14.70 of ImmunoGen Inc.¹⁷
• Sep 22, 2023Exercised options 10,000 shares at $14.70 of ImmunoGen Inc.¹⁸
• Sep 22, 2023Bought 25,000 shares at $1.41 of Precigen, Inc¹⁹
• May 2, 2023Granted 9,132 shares of Theravance Biopharma, Inc.²⁰
• Mar 24, 2023Bought 50,000 shares at $0.84 of Praxis Precision Medicines, Inc.²¹
• Mar 9, 2023Granted 48,290 shares at $1.17 of Precigen, Inc²²
• Feb 22, 2023Exercised options 61,576 shares of Precigen, Inc²³
• Jun 8, 2022Bought 25,000 shares at $1.81 of Praxis Precision Medicines, Inc.²⁴
• Apr 26, 2022Granted 9,852 shares of Theravance Biopharma, Inc.²⁵
• Mar 25, 2022Exercised options 16,212 shares of Precigen, Inc²⁶
• Feb 22, 2022Granted 27,832 shares at $2.03 of Precigen, Inc²⁷
• Sep 10, 2003Granted 10,000 shares of Bristol-Myers Squibb⁸